These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23721058)

  • 21. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 120(6):871-6. PubMed ID: 17331567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urokinase-type plasminogen activator and metalloproteinase-2 are independently related to the carotid atherosclerosis in haemodialysis patients.
    Pawlak K; Pawlak D; Myśliwiec M
    Thromb Res; 2008; 121(4):543-8. PubMed ID: 17706748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema.
    Hilty MP; Zügel S; Schoeb M; Auinger K; Dehnert C; Maggiorini M
    Mediators Inflamm; 2016; 2016():1942460. PubMed ID: 27378823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients.
    Kaysen GA; Levin NW; Mitch WE; Chapman AL; Kubala L; Eiserich JP
    Blood Purif; 2006; 24(5-6):508-16. PubMed ID: 17077623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in ankylosing spondylitis.
    Toldi G; Szalay B; Bekő G; Kovács L; Vásárhelyi B; Balog A
    Joint Bone Spine; 2013 Jan; 80(1):96-8. PubMed ID: 22999906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular cell adhesion molecule 1, soluble Fas and hepatocyte growth factor as predictors of mortality in nonagenarians: the Vitality 90+ study.
    Kämppä N; Mäkelä KM; Lyytikäinen LP; Peltonen N; Hautamäki J; Seppälä I; Mononen N; Goebeler S; Karhunen PJ; Hervonen A; Hurme M; Jylhä M; Lehtimäki T
    Exp Gerontol; 2013 Nov; 48(11):1167-72. PubMed ID: 23911532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
    Mekonnen G; Corban MT; Hung OY; Eshtehardi P; Eapen DJ; Al-Kassem H; Rasoul-Arzrumly E; Gogas BD; McDaniel MC; Pielak T; Thorball CW; Sperling L; Quyyumi AA; Samady H
    Atherosclerosis; 2015 Mar; 239(1):55-60. PubMed ID: 25574858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission.
    Toldi G; Bekő G; Kádár G; Mácsai E; Kovács L; Vásárhelyi B; Balog A
    Clin Chem Lab Med; 2013 Feb; 51(2):327-32. PubMed ID: 22718576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women.
    Piché ME; Lemieux S; Weisnagel SJ; Corneau L; Nadeau A; Bergeron J
    Am J Cardiol; 2005 Jul; 96(1):92-7. PubMed ID: 15979442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
    Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
    Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Waist circumference is related to low-grade inflammation in youth.
    Steene-Johannessen J; Kolle E; Reseland JE; Anderssen SA; Andersen LB
    Int J Pediatr Obes; 2010 Aug; 5(4):313-9. PubMed ID: 20078378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.
    Eugen-Olsen J; Andersen O; Linneberg A; Ladelund S; Hansen TW; Langkilde A; Petersen J; Pielak T; Møller LN; Jeppesen J; Lyngbaek S; Fenger M; Olsen MH; Hildebrandt PR; Borch-Johnsen K; Jørgensen T; Haugaard SB
    J Intern Med; 2010 Sep; 268(3):296-308. PubMed ID: 20561148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
    Persson M; Engström G; Björkbacka H; Hedblad B
    Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of selected inflammatory markers in patients with stable renal graft (RTx) 36 months after transplantation].
    Krzanowski M; Stompór T; Kuśnierz-Cabala B; Ignacak E; Sułowicz W; Naskalski JW
    Przegl Lek; 2006; 63(8):597-601. PubMed ID: 17441364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.
    Böcskei RM; Benczúr B; Losonczy G; Illyés M; Cziráki A; Müller V; Bohács A; Bikov A
    Lung; 2019 Apr; 197(2):189-197. PubMed ID: 30820636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men.
    Haugaard SB; Andersen O; Hansen TW; Eugen-Olsen J; Linneberg A; Madsbad S; Olsen MH; Jørgensen T; Borch-Johnsen K; Jeppesen J
    Diabet Med; 2012 Apr; 29(4):479-87. PubMed ID: 22050462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of suPAR and hs-CRP on cardiovascular disease.
    Diederichsen MZ; Diederichsen SZ; Mickley H; Steffensen FH; Lambrechtsen J; Sand NPR; Christensen KL; Olsen MH; Diederichsen A; Grønhøj MH
    Atherosclerosis; 2018 Apr; 271():245-251. PubMed ID: 29402404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
    Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
    Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients.
    Malyszko J; Malyszko JS; Kozminski P; Pawlak K; Mysliwiec M
    Nephrology (Carlton); 2007 Jun; 12(3):246-53. PubMed ID: 17498119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in haemodialysis patients.
    Borawski J; Myśliwiec M
    Nephrol Dial Transplant; 2002 Apr; 17(4):637-44. PubMed ID: 11917058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.